Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.93 USD | -1.17% |
|
+7.32% | +63.05% |
06-22 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
05-29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.05% | 1.63B | |
+17.94% | 126B | |
+22.82% | 118B | |
+23.26% | 27.87B | |
-18.59% | 20.95B | |
-15.13% | 16.92B | |
-15.69% | 16.18B | |
+9.64% | 14.84B | |
-46.10% | 14.79B | |
+52.31% | 14.08B |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- Transcript : MannKind Corp. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 07